CRSP Latest Headlines

Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — Key Trends for 2026

at www.tipranks.com (Fri, 2-Jan 7:59 AM)

ARK outperforms in 2025 with Tesla still Cathie Wood’s biggest bet

at seekingalpha.com (Thu, 1-Jan 3:55 AM)

Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock

at seekingalpha.com (Mon, 29-Dec 8:15 AM)

Cathie Wood’s ARK Adds to CRISPR Stock — Here’s What Else It Traded This Week

at www.tipranks.com (Mon, 29-Dec 1:12 AM)

CRISPR Therapeutics Shows Up to 89% Lipid Reduction in Phase 1 Data—Gene Editing in Cardiovascular Disease Advances

Market Chameleon (Thu, 20-Nov 8:25 AM)

CRISPR Therapeutics Reports Strong Pipeline Momentum and Robust Cash Position—Phase 1 CTX310 Data Published in NEJM

Market Chameleon (Mon, 10-Nov 8:12 AM)

CTX460 Achieves Over 90% Gene Correction in Preclinical AATD Models—SyNTase Platform Shows Durable, Targeted Editing

Market Chameleon (Fri, 10-Oct 8:11 AM)

Monash University’s New Boston Hub Strengthens Global Biotech Collaboration—CRISPR Therapeutics Among Key Partners

Market Chameleon (Thu, 2-Oct 7:12 AM)